Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
viral vectors
Manufacturing
OXB expands BMS partnership for CAR-T lentiviral vectors
OXB, a U.K. CDMO, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.
Joseph Keenan
Feb 4, 2026 10:25am
FDA restricts bluebird's gene therapy after blood cancer reports
Aug 8, 2025 11:19am
FDA investigates 2 deaths after Sarepta Duchenne gene therapy
Jun 25, 2025 10:26am
2nd patient dies after Sarepta's DMD gene therapy Elevidys
Jun 16, 2025 10:58am
BMS calls it quits on vector production at former Novartis plant
May 2, 2025 11:20am
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
Mar 18, 2025 10:34am